Protective efficacy of an RBD-based Middle East respiratory syndrome coronavirus (MERS-CoV) particle vaccine in llamas

Overview of attention for article published in One Health Outlook, June 2022

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (86th percentile)

Mentioned by

news: 1 news outlet

twitter: 5 X users

Citations

dimensions_citation: 4 Dimensions

Readers on

mendeley: 6 Mendeley

Summary News X Dimensions citations

So far, Altmetric has seen 6 X posts from 5 X users, with an upper bound of 5,712 followers.

RT @Rodon_J: 🦠🔬👩🏻‍🔬 En el @CReSA_r @irtacat hace años que estudiamos coronaviruses con potencial pandémico. Es importante tener herramienta…

Reply Repost Favourite

RT @QuimSegales: Vacunación usando proteína S expresada en un vector MVA en dromedarios: https://t.co/AdT7hkYNRw Vacunación usando proteín…

Reply Repost Favourite

Vacunación usando proteína S expresada en un vector MVA en dromedarios: https://t.co/AdT7hkYNRw Vacunación usando proteína S recombinante en llamas: https://t.co/8VPoA70AxO Vacunación basada en RBD (receptor binding domain) en llamas: https://t.co/180RCb

Reply Repost Favourite

Moltes felicitats, @Rodon_J... un molt bon treball de nou. Vinga, que tenim la defensa de la Tesi a tocar!!!!

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 2 additional X posts.